Daniel Donohue is a Cardiology physician affiliated with New York University. OpenAlex indexes 12 publications with 382 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
975 Stewart Ave
Garden City, NY 115304816
Telephone
516-222-8650Provider last certified this registry record 4 Nov 2022.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Teleflex LLCProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year202413 payments
- Abbott LaboratoriesProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
89.9%Adenosine Receptor Agonist24.2%Regadenoson100%Part B, office-administered≥182 patientsStatin17.7%Atorvastatin Calcium59%Rosuvastatin Calcium37%Simvastatin2%Pravastatin Sodium2%Part D<11 patients+ 15 more classes in this area
Blood & clotting
9.6%Factor Xa inhibitor6.8%Eliquis82%Xarelto18%Part D≥38 patientsP2Y12 inhibitor2.5%Clopidogrel100%Part D≥35 patients+ 1 more class in this area
Metabolism & gastrointestinal
0.5%Potassium supplement0.5%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A LOTUS UPSTREAM; UNUSUAL CASE OF RETROGRADE TAVR VALVE MIGRATION
Journal of the American College of Cardiology
2023 - SHORT-TERM PROGNOSTIC IMPLICATIONS OF B-TYPE NATRIURETIC PEPTIDE IN TRANSCATHETER MITRAL VALVE REPAIR
Journal of the American College of Cardiology
2021 - A BALANCING ACT: THE IMPACT OF REDUCING MITRAL REGURGITATION AT THE EXPENSE OF INCREASED MITRAL GRADIENTS USING PERCUTANEOUS MITRAL VALVE REPAIR
Journal of the American College of Cardiology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Kenneth Alper, MD
New York University
William Rom, MD
New York University
Alec Megibow, MD
New York University
Jerry Shapiro, MD
New York University
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”